Cargando…

Asian Population Is More Prone to Develop High-Risk Myelodysplastic Syndrome, Concordantly with Their Propensity to Exhibit High-Risk Cytogenetic Aberrations

SIMPLE SUMMARY: The world population is genetically and environmentally diverse. In particular, genetic differences related to an ethnic factor may underlie differences in cancer phenotypic expression. Therefore, we compared the epidemiology, and the clinical, biological and genetic characteristics...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Yan, Eveillard, Jean-Richard, Couturier, Marie-Anne, Soubise, Benoit, Chen, Jian-Min, Gao, Sujun, Basinko, Audrey, Morel, Frédéric, Douet-Guilbert, Nathalie, Troadec, Marie-Bérengère
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865620/ https://www.ncbi.nlm.nih.gov/pubmed/33513838 http://dx.doi.org/10.3390/cancers13030481

Ejemplares similares

Cytogenetic and Genetic Abnormalities with Diagnostic Value in Myelodysplastic Syndromes (MDS): Focus on the Pre-Messenger RNA Splicing Process
por: Douet-Guilbert, Nathalie, et al.
Publicado: (2022)

TP53 in Myelodysplastic Syndromes
por: Jiang, Yan, et al.
Publicado: (2021)

RBM22, a Key Player of Pre-mRNA Splicing and Gene Expression Regulation, Is Altered in Cancer
por: Soubise, Benoît, et al.
Publicado: (2022)

Using Bacterial Artificial Chromosomes in Leukemia Research: The Experience at the University Cytogenetics Laboratory in Brest, France
por: De Braekeleer, Etienne, et al.
Publicado: (2011)

Cytogenetic features in myelodysplastic syndromes
por: Haase, Detlef
Publicado: (2008)

ETV6-RUNX1 and RUNX1 directly regulate RAG1 expression: one more step in the understanding of childhood B-cell acute lymphoblastic leukemia leukemogenesis
por: Jakobczyk, Hélène, et al.
Publicado: (2021)

Myelodysplastic Syndrome in Pakistan: Clinicohematological Characteristics, Cytogenetic Profile, and Risk Stratification
por: Mahmood, Rafia, et al.
Publicado: (2018)

Rare Cytogenetic Abnormalities in Myelodysplastic Syndromes
por: Bacher, Ulrike, et al.
Publicado: (2015)

Cytogenetic Abnormalities in Myelodysplastic Syndromes: An Overview
por: Zahid, Mohammad Faizan, et al.
Publicado: (2017)

Chromosomal instability correlates with poor outcome in patients with myelodysplastic syndromes irrespectively of the cytogenetic risk group
por: Heilig, Christoph E, et al.
Publicado: (2010)

Cytogenetic features in primary myelodysplastic syndrome Egyptian patients
por: Elnahass, Yasser, et al.
Publicado: (2018)

Where are we with unintended effects in genome editing applications from DNA to phenotype: focus on plant applications
por: Troadec, Marie-Bérengère, et al.
Publicado: (2019)

Multiple cytogenetics forms of KMT2A amplification and jumping translocation in a case of myelodysplastic syndrome
por: Ittel, Antoine, et al.
Publicado: (2021)

Cytogenetic profile of Indian patients with de novo myelodysplastic syndromes
por: Chaubey, Rekha, et al.
Publicado: (2011)

Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?
por: Saumell, Sílvia, et al.
Publicado: (2015)

Clinicohematological and cytogenetic profile of myelodysplastic syndromes in Pakistan-compare and contrast
por: Anwar, Nida, et al.
Publicado: (2017)

Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA
por: Garcia-Gisbert, Nieves, et al.
Publicado: (2022)

Cytogenetic characteristics in Vietnamese patients diagnosed with primary myelodysplastic syndromes()
por: Vu, Minh Phuong, et al.
Publicado: (2022)

Combining cytogenetic and epigenetic approaches in chronic lymphocytic leukemia improves prognosis prediction for patients with isolated 13q deletion
por: Bagacean, Cristina, et al.
Publicado: (2017)

Clinicopathological Characteristics of Hyperdiploidy with High-Risk Cytogenetics in Multiple Myeloma
por: Yang, Naery, et al.
Publicado: (2018)

Multiple myeloma with high-risk cytogenetics and its treatment approach
por: Hanamura, Ichiro
Publicado: (2022)

The evaluation of the outcome in myelodysplastic patients by using non-cytogenetic prognostic scores
por: Căzăceanu, O, et al.
Publicado: (2014)

Myelodysplastic syndromes: advantages of a combined cytogenetic and molecular diagnostic workup
por: Ciabatti, Elena, et al.
Publicado: (2017)

Severe Eosinophilia in Myelodysplastic Syndrome With a Defined and Rare Cytogenetic Abnormality
por: Rai, Shinya, et al.
Publicado: (2019)

PB1996: CYTOGENETIC FEATURES OF 164 MOROCCAN PATIENTS WITH MYELODYSPLASTIC SYNDROME
por: Aghoutane, Yossra, et al.
Publicado: (2023)

Part 5: Myelodysplastic syndromes—Treatment of high-risk disease
por: Magalhães, Silvia Maria Meira, et al.
Publicado: (2018)

Emerging treatment options for patients with high-risk myelodysplastic syndrome
por: Bewersdorf, Jan Philipp, et al.
Publicado: (2020)

PB2020: OUTCOMES OF PATIENTS WITH HIGH RISK MYELODYSPLASTIC SYNDROMES
por: Amor, Imen Ben, et al.
Publicado: (2023)

Clonal evolution in UKE-1 cell line leading to an increase in JAK2 copy number
por: Buors, C, et al.
Publicado: (2012)

Cytogenetic as an Important Tool for Diagnosis and Prognosis for Patients with Hypocellular Primary Myelodysplastic Syndrome
por: Corrêa de Souza, Daiane, et al.
Publicado: (2014)

Phenotypic and Cytogenetic Characterization of Mesenchymal Stromal Cells in De Novo Myelodysplastic Syndromes
por: Rathnayake, A. J. I. S., et al.
Publicado: (2016)

P708: HIGH MUTATIONAL CONCORDANCE IN PAIRED BONE MARROW AND PERIPHERAL BLOOD SAMPLES IN PATIENTS WITH CONFIRMED OR SUSPECTED MYELODYSPLASTIC NEOPLASM
por: Wossidlo, Natalie, et al.
Publicado: (2023)

Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes
por: Abáigar, María, et al.
Publicado: (2016)

Analysis of the efficacy of lenalidomide in patients with intermediate-1 risk myelodysplastic syndrome without 5q deletion
por: YANG, YAN, et al.
Publicado: (2013)

MACS-annexin V cell sorting of semen samples with high TUNEL values decreases the concentration of cells with abnormal chromosomal content: a pilot study
por: El Fekih, Sahar, et al.
Publicado: (2021)

Subgroup analysis of ICARIA‐MM study in relapsed/refractory multiple myeloma patients with high‐risk cytogenetics
por: Harrison, Simon J., et al.
Publicado: (2021)

Clinical, hematological, and cytogenetic profile of adult myelodysplastic syndrome in a tertiary care center
por: Narayanan, Santhosh
Publicado: (2017)

Cytogenetic characteristics of 665 patients with myelodysplastic syndrome in China: A single-center report
por: Wang, Xueying, et al.
Publicado: (2021)

Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes
por: Yan, Xuefen, et al.
Publicado: (2021)

PB1914: CYTOGENETIC FINDINGS IN 18 CHILDREN WITH MYELODYSPLASTIC SYNDROMES BY KARYOTYPIC AND FISH ANALYSIS
por: Manola, K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4bs0nf0aumqs3qrltj48k0r6l0